232 related articles for article (PubMed ID: 23003922)
1. RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects.
Wang ZZ; Zhang Y; Liu YQ; Zhao N; Zhang YZ; Yuan L; An L; Li J; Wang XY; Qin JJ; Wilson SP; O'Donnell JM; Zhang HT; Li YF
Br J Pharmacol; 2013 Feb; 168(4):1001-14. PubMed ID: 23003922
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
[TBL] [Abstract][Full Text] [Related]
5. Chlorbipram: a novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer.
Zhang MZ; Zhou ZZ; Yuan X; Cheng YF; Bi BT; Gong MF; Chen YP; Xu JP
Eur J Pharmacol; 2013 Dec; 721(1-3):56-63. PubMed ID: 24113523
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice.
Zhang C; Cheng Y; Wang H; Wang C; Wilson SP; Xu J; Zhang HT
J Alzheimers Dis; 2014; 38(2):269-80. PubMed ID: 23948935
[TBL] [Abstract][Full Text] [Related]
7. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses.
Zhou ZZ; Cheng YF; Zou ZQ; Ge BC; Yu H; Huang C; Wang HT; Yang XM; Xu JP
ACS Chem Neurosci; 2017 Jan; 8(1):135-146. PubMed ID: 27690383
[TBL] [Abstract][Full Text] [Related]
8. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs.
Zhang HT
Curr Pharm Des; 2009; 15(14):1688-98. PubMed ID: 19442182
[TBL] [Abstract][Full Text] [Related]
10. Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice.
Guo J; Lin P; Zhao X; Zhang J; Wei X; Wang Q; Wang C
Neuroscience; 2014 Mar; 263():1-14. PubMed ID: 24434771
[TBL] [Abstract][Full Text] [Related]
11. A new model of Pde4d deficiency: genetic knock-down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects.
Schaefer TL; Braun AA; Amos-Kroohs RM; Williams MT; Ostertag E; Vorhees CV
Genes Brain Behav; 2012 Jul; 11(5):614-22. PubMed ID: 22487514
[TBL] [Abstract][Full Text] [Related]
12. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor--an approach using rodent behavioral antidepressant tests battery.
Jindal A; Mahesh R; Gautam B; Bhatt S; Pandey D
Eur J Pharmacol; 2012 Aug; 689(1-3):125-31. PubMed ID: 22698578
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents.
Gong MF; Wen RT; Xu Y; Pan JC; Fei N; Zhou YM; Xu JP; Liang JH; Zhang HT
Psychopharmacology (Berl); 2017 Oct; 234(20):3143-3151. PubMed ID: 28748375
[TBL] [Abstract][Full Text] [Related]
16. The PDE4 cAMP-Specific Phosphodiesterases: Targets for Drugs with Antidepressant and Memory-Enhancing Action.
Bolger GB
Adv Neurobiol; 2017; 17():63-102. PubMed ID: 28956330
[TBL] [Abstract][Full Text] [Related]
17. PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice.
McDonough W; Aragon IV; Rich J; Murphy JM; Abou Saleh L; Boyd A; Koloteva A; Richter W
FASEB J; 2020 Sep; 34(9):12533-12548. PubMed ID: 32738081
[TBL] [Abstract][Full Text] [Related]
18. GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.
Bruno O; Fedele E; Prickaerts J; Parker LA; Canepa E; Brullo C; Cavallero A; Gardella E; Balbi A; Domenicotti C; Bollen E; Gijselaers HJ; Vanmierlo T; Erb K; Limebeer CL; Argellati F; Marinari UM; Pronzato MA; Ricciarelli R
Br J Pharmacol; 2011 Dec; 164(8):2054-63. PubMed ID: 21649644
[TBL] [Abstract][Full Text] [Related]
19. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
Campos-Toimil M; Keravis T; Orallo F; Takeda K; Lugnier C
Br J Pharmacol; 2008 May; 154(1):82-92. PubMed ID: 18311187
[TBL] [Abstract][Full Text] [Related]
20. Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior.
Hansen RT; Conti M; Zhang HT
Psychopharmacology (Berl); 2014 Aug; 231(15):2941-54. PubMed ID: 24563185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]